Siga Technologies INC Deferred Costs, Noncurrent
Siga Technologies INC (SIGA) had Deferred Costs, Noncurrent of $0 as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2019-03-06
- 2018-12-31: Deferred Costs, Noncurrent $0.00.
- 2018-09-30: Deferred Costs, Noncurrent $0.00.
- 2018-06-30: Deferred Costs, Noncurrent $0.00.
- 2018-03-31: Deferred Costs, Noncurrent $94.30M.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $94.30M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $96.59M 10-K · filed 2019-03-06 |
| 2017-09-30 | $96.74M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $83.19M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $79.04M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $72.65M 10-K · filed 2018-03-06 |
| 2016-09-30 | $74.39M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $56.19M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $53.04M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $52.94M 10-K · filed 2017-03-07 |
| 2015-09-30 | $54.31M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $45.96M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $38.29M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $32.86M 10-K · filed 2016-03-04 |
| 2014-09-30 | $32.81M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $30.10M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $29.18M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $22.58M 10-K · filed 2015-03-06 |
| 2013-09-30 | $21.89M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $14.23M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $8.67M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $2.84M 10-K · filed 2014-03-10 |
| 2012-09-30 | $2.40M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $1.94M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $1.51M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $250.07K 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |